Abstract:Miaomiao Sun, 1– 3, &ast Fuquan Wang, 1– 3, &ast Haopeng Li, 1– 3 Mengyu Li, 1– 3 Yu Wang, 1– 3 Chenchen Wang, 1– 3 Yan Zhang, 1– 3 Dingyu Zhang, 1– 4 Jianhua Li, 5 Shanglong Yao 1– 3 1 Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China; 2 Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China; 3 Key Laboratory of Anesthesiology and Resuscitation (Huazhong University of Science and Technology), Ministry of Education, Wuhan, 430022, People's Republic of China; 4 Wuhan Jinyintan Hospital, Wuhan, 430023, People's Republic of China; 5 Department of Critical Care Medicine, Chongqing University Jiangjin Hospital, Chongqing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Shanglong Yao; Jianhua Li, Email ; Background: Sepsis-associated acute kidney injury (SA-AKI) is a common complication in patients with sepsis, triggering high morbidity and mortality. Maresin-1 (MaR1) is a pro-resolution lipid mediator that promotes the resolution of acute inflammation and protects organs from inflammation. Methods: In this study, we established an SA-AKI model using cecal ligation and puncture (CLP) and investigated the effect and mechanism of MaR1. The blood and kidneys were harvested 24 hours after surgery. The blood biochemical/routine indicators, renal function, SA-AKI-related pathophysiological processes, and AMPK/SIRT3 signaling in septic mice were observed by histological staining, immunohistochemical staining, Western blot, qPCR, ELISA and TUNEL Assay. Results: MaR1 treatment alleviated kidney injury in septic mice, reflected in improved pathological changes in renal structure and renal function. MaR1 treatment decreased the levels of serum creatinine (sCr) and blood urea nitrogen (BUN) and the expressions of KIM-1, NGAL and TIMP-2, which were related to kidney injury, while inhibited the expressions of inflammatory factors TNF-α, IL-1β and IL-6. The expression of endoplasmic reticulum stress-related indicators p-PERK/PERK, GRP78, p-EIF2α/EIF2α, ATF4, CHOP, and pyroptosis-related indicators Caspase-1, NLRP3, GSDMD, IL-18, and IL-1β also decreased after MaR1 treatment. The mechanism may be related to the activation of the AMPK/SIRT3 signaling pathway, and an AMPK inhibitor (compound C) partially reverses MaR1's protective effects in septic mice. Conclusion: Taken together, these findings suggest that MaR1 may partially ameliorate SA-AKI by activating the AMPK/SIRT3 signaling pathway, providing a potential new perspective for research on SA-AKI. Keywords: Maresin-1, pyroptosis, AMPK/SIRT3, endoplasmic reticulum stress, sepsis-associated acute kidney injury, inflammation The kidney is one of the earliest organs to suffer damage in sepsis. 1,2 A worse prognosis was predicted by SA-AKI than by the two symptoms separately. 3,4 SA-AKI might have a direct mechanism caused by an infection or the host's response to an infection, or it can have an indirect mechanism brought on by sepsis or the unfavorable effects of sepsis treatment. 5,6 In addition, recent studies have shown that the pathological process of SA-AKI may be related to excessive inflammatory response, ER stress, and pyroptosis, especially pyroptosis of tubule cells, which is highly distinct from other types of acute kidney injury (AKI). 7–9 Given the significant mortality and morbidity caused by SA-AKI, it is becoming more and more important to fully comprehend its cellular pathophysiological mechanisms and persistently investigate new therapeutic approaches for SA-AKI. 3 Maresin-1 (MaR1), a pro-resolution lipid mediator produced from docosahexaenoic acid, was initially identified in human macrophages. Its anti-inflammatory and pro-resolution properties help to promote the resolution of acute inflammation and protect organs from inflammation. 10,11 By reducing the inflammatory response, oxidative stress, ER stress, pyroptosis, and apoptosis, these protective effects are primarily accomplished. 11–15 MaR1 has been thoroughly studied, but its regulatory mechanism, notably in SA-AKI, is yet unknown. Adenosine monophosphate activated protein kinase (AMPK) plays an important role in regulating energy homeostasis and a variety of signaling pathways, and studies have shown that AMPK can be involved in the regulation of inflammation and oxidative stress.<sup -Abstract Truncated-

Abstract 14951: Maresin 1 Induces Cardiomyocyte Hypertrophy Through RORα/IGF-1/PI3K/Akt Pathway

The Pro-Resolving Lipid Mediator Maresin 1 (MaR1) Attenuates Inflammatory Signaling Pathways in Vascular Smooth Muscle and Endothelial Cells

Maresin-1 Protects Against Pulmonary Arterial Hypertension by Improving Mitochondrial Homeostasis Through ALXR/HSP90α Axis.

Maresin1 ameliorates ventricular remodelling and arrhythmia in mice models of myocardial infarction via NRF2/HO-1 and TLR4/NF-kB signalling

Maresin 1 Protects Against Lipopolysaccharide/d-Galactosamine-induced Acute Liver Injury by Inhibiting Macrophage Pyroptosis and Inflammatory Response.

Maresin-1 protects against pulmonary arterial hypertension by improving mitochondrial homeostasis through ALXR/HSP90a axis

Maresin‐1 Ameliorates Hypertensive Vascular Remodeling Through Its Receptor LGR6

Maresin 1 alleviates the inflammatory response, reduces oxidative stress and protects against cardiac injury in LPS-induced mice

Phosphatase PPM1L Prevents Excessive Inflammatory Responses and Cardiac Dysfunction after Myocardial Infarction by Inhibiting IKKβ Activation.

Maresin1: A multifunctional regulator in inflammatory bone diseases

Macrophage Rmp Ameliorates Myocardial Infarction by Modulating Macrophage Polarization in Mice

Maresin 1 attenuates pro-inflammatory reactions and ER stress in HUVECs via PPARα-mediated pathway

The Pro-Resolving Lipid Mediator Maresin 1 Protects Against Cerebral Ischemia/reperfusion Injury by Attenuating the Pro-Inflammatory Response.

Role of Myofibrillogenesis Regulator-1 in Myocardial Hypertrophy

Recombinant High‑mobility Group Box 1 Induces Cardiomyocyte Hypertrophy by Regulating the 14‑3‑3η, PI3K and Nuclear Factor of Activated T Cells Signaling Pathways.

Matairesinol blunts adverse cardiac remodeling and heart failure induced by pressure overload by regulating Prdx1 and PI3K/AKT/FOXO1 signaling

Maresin 1 Inhibits Epithelial-To-Mesenchymal Transition In Vitro And Attenuates Bleomycin Induced Lung Fibrosis In Vivo

Long Noncoding RNA Myocardial Infarction‑associated Transcript is Associated with the Microrna‑150‑5p/p300 Pathway in Cardiac Hypertrophy.

Maresin-1 promotes neuroprotection and prevents disease progression in experimental models of multiple sclerosis through metabolic reprogramming and shaping innate and adaptive disease-associated cell types

The acute phase protein alpha2-macroglobulin induces rat ventricular cardiomyocyte hypertrophy via ERK1,2 and PI3-kinase/Akt pathways

Maresin-1 Attenuates Sepsis-Associated Acute Kidney Injury via Suppressing Inflammation, Endoplasmic Reticulum Stress and Pyroptosis by Activating the AMPK/SIRT3 Pathway